Table 1.
Patient characteristics during baseline and intervention phases of trial
| Characteristics | Baseline phase (n=3519) | Intervention phase (n=2845) |
|---|---|---|
| Women | 1398 (39.7) | 1110 (39.0) |
| Mean (SD) age | 60.7 (15.8) | 60.9 (15.9) |
| Ethnicity: | ||
| Asian* | 293 (8.3) | 240 (8.4) |
| White | 2250 (63.9) | 1822 (64.0) |
| First Nations† | 378 (10.7) | 342 (12.0) |
| Pacific Islander‡ | 89 (2.5) | 63 (2.2) |
| Other or not recorded | 509 (14.5) | 378 (13.3) |
| Diabetes mellitus: | ||
| Diet controlled | 304 (8.6) | 172 (6.0) |
| Drug controlled | 1251 (35.5) | 1049 (36.9) |
| Immunosuppressant use | 472 (13.4) | 372 (13.1) |
SD=standard deviation.
Up to 156 patients (2.3%) were transferred between centres (participating and non-participating) and have contributed more than once to characteristics. Values are numbers (percentages) unless stated otherwise.
*
Includes Chinese, Malay, Filipino, Vietnamese, and Indonesian.
†
Included Aboriginal and Torres Strait Islander and Māori.
‡
Included Tongan, Samoan, and Cook Islander.